Tickerplace logo

Tickerplace

Actuate Therapeutics Inc logo

ACTUActuate Therapeutics Inc

ACTU Stock Price, Valuation & Chart | Actuate Therapeutics Inc

Compare
$1.300-0.24 (-15.58%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyACTU intrinsic valueACTU calculated fair value vs price
OverviewFinancialsDividendsRatios

ACTU Historical price chart

ACTU Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization31.10M
PE Ratio-1.49
EPS-0.87
Trading Volume329.02K
Today's High/Low1.55/1.3
Dividend Yield0.00
52 Week High/Low9.22/0.9
Shares Outstanding23.93M
ACTU Financial Statement
ACTU Analyst ratings
ACTU Analysis & performance metrics

ACTU Company profile

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is…

ACTU Management team

Management
Paul J. Lytle CPACFO
Chief Financial Officer
Alan Kozikowski Ph.D.
Scientific Founder and Advisor
Daniel M. SchmittCEO
Chief Executive Officer, President & Director
Andrew P. Mazar Ph.D.COO
Co-Founder & Chief Operating Officer
Total 4 executives

ACTU Frequently asked questions

What is Actuate Therapeutics Inc (ACTU) Stock Price?

Current stock price of Actuate Therapeutics Inc (ACTU) stock is $1.300. The stock price is -15.58% lower in the session. The intraday range can be seen from this page. Volume of Actuate Therapeutics Inc (ACTU) stock is 329.02K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Actuate Therapeutics Inc (ACTU) stock price going up or down today?

The stock price of Actuate Therapeutics Inc (ACTU) can change with earnings, company news, and overall market sentiment. Actuate Therapeutics Inc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Actuate Therapeutics Inc stock expensive at its current price?

Whether Actuate Therapeutics Inc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ACTU on this page is -1.49. EPS on this page is -0.87. Compare those figures with peers and growth expectations before deciding if the current Actuate Therapeutics Inc price is justified.

How has the stock price of Actuate Therapeutics Inc (ACTU) performed historically?

Historical performance for Actuate Therapeutics Inc (ACTU) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ACTU reacted to past earnings and market events.

Should I buy Actuate Therapeutics Inc (ACTU) stock, at this price?

Buying Actuate Therapeutics Inc (ACTU) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.